Spontaneously hypertensive rats develop pronounced hepatic steatosis induced by choline‐deficient diet: Evidence for hypertension as a potential enhancer in non‐alcoholic steatohepatitis
Authors:
- 19 December 2011
- journal article
- Published by Wiley in Hepatology Research
- Vol. 42 (3) , 310-320
Abstract
Aim: Patients with non-alcoholic steatohepatitis (NASH) frequently have many co-morbidities including essential hypertension, which is reported to increase vascular production of reactive oxygen species (ROS) and alter the hepatic anti-oxidant defense system. Since ROS play a role in the pathogenesis of NASH, it is hypothesized that hypertension modulates the hepatic oxidative status and influences the development of NASH. The aim of this study was to investigate the potential effects of hypertension on the progression of NASH. Methods: Spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats as normotensive controls were fed choline-deficient (CD) diet for 5 weeks. Histological changes, messenger RNA (mRNA) expression and thiobarbituric acid reactive substances (TBARS) levels in the liver were assessed in each group. Results: Choline-deficient diet led to pronounced hepatic steatosis in SHR with an 8-fold increase of the hepatic triglyceride content, while there was no significant increase in WKY. These changes in SHR were associated with significant reduction in the expression of mRNA for peroxisome proliferator activated receptor α, acyl-CoA oxidase, microsomal triglyceride transfer protein, and apolipoprotein B100. Consistent with the significant reduction of hepatic superoxide dismutase activity and marked downregulation of the gene expression of hepatic antioxidant enzymes, the hepatic TBARS level and the plasma level of alanine aminotransferase were only increased in SHR on CD diet. Conclusions: Spontaneously hypertensive rats receiving CD diet showed severe hepatic steatosis associated with reduction of hepatic anti-oxidant capacity, leading to increased hepatic oxidative stress and tissue damage. Accordingly, hypertension might have a potential effect on the progression of NASH.Keywords
This publication has 47 references indexed in Scilit:
- Bach1 gene ablation reduces steatohepatitis in mouse MCD diet modelJournal of Clinical Biochemistry and Nutrition, 2010
- Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretionNutrition & Metabolism, 2010
- Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 RatsThe American Journal of Pathology, 2009
- PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acidω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseasePPAR Research, 2009
- Mitochondria, oxidative stress and cell deathApoptosis, 2007
- Antioxidant activity of propionyl-l-carnitine in liver and heart of spontaneously hypertensive ratsLife Sciences, 2006
- Antioxidant Activities and Oxidative Stress Byproducts in Human HypertensionHypertension, 2003
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- Plasma Hydrogen Peroxide Production in Human Essential HypertensionHypertension, 2000
- Role of Angiotensin and Oxidative Stress in Essential HypertensionHypertension, 1999